SV Health Investors, LLC

Q2 2016 13F Holdings Report, Stock Holdings

Signature - Title
Denise W. Marks - CFO
Location
Boston, MA
Holdings as of
30 Jun 2016
Value $
$99,043,000
Num holdings
6
Filing time
12 Aug 2016, 06:04:29 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ENTL, CATB, OCUL, TRXC, and RPTP.
Previous filing
Q1 2016 - 13 May 2016
Next filing
Q3 2016 - 14 Nov 2016
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2016 Q2 compared to 2016 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Denise W. Marks CFO Boston, Massachusetts 12 Aug 2016

The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Life Sciences Advisers, LLC, a Delaware limited liability company ("Advisers"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co-Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund III Entities and the Fund V Entities together, the "Funds"), directly own certain security positions reported by Advisers, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Advisers are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Advisers may be deemed to share voting power and control over the shares held by the Fund IV Entities. Advisers may be deemed to share voting power and control over the shares held by the Fund III Entities and the Fund V Entities. Each of SVLS IV GP, SVLSF IV, LLC and Advisers disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein.

Other Included Managers (2):

Num Name Location File Number
1 SVLSF IV, LLC Boston, MA 028-16272
2 SV Life Sciences Fund IV (GP), L.P. Boston, MA 028-16273